The development of immunoconjugates for targeted cancer therapy
about
Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapyAntibody-drug conjugates as novel anti-cancer chemotherapeuticsMechanisms of action of therapeutic antibodies for cancerHigh throughput cytotoxicity screening of anti-HER2 immunotoxins conjugated with antibody fragments from phage-displayed synthetic antibody librariesRecent Advances in the Development of Antineoplastic Agents Derived from Natural ProductsPhotonanomedicine: a convergence of photodynamic therapy and nanotechnology.Trial Watch: Immunotherapy plus radiation therapy for oncological indications.Immunotherapeutic advancements for glioblastoma.In vivo imaging with antibodies and engineered fragments.Keratinocyte growth factor receptor: a therapeutic target in solid cancer.Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances.The future of antiviral immunotoxins.Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.Advances in the development of aptamer drug conjugates for targeted drug delivery.An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia.Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers.New mechanism for release of endosomal contents: osmotic lysis via nigericin-mediated K+/H+ exchange.Disulfide-bridging PEGylation during refolding for the more efficient production of modified proteins.Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C.Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives.
P2860
Q24187274-212523D6-CD12-4DB0-8A39-BE5E49A69C3CQ26800175-F314DBB6-94C6-4916-B44F-0B19A4CF088EQ28385366-D35E6DBC-DCF5-423B-8FBD-411F38126F5FQ36109883-B402FEB6-27EE-45A8-9C4C-B439046FBF42Q36273796-BAA42A66-132F-4A3E-8C7F-1B7989ED080BQ37115994-FCEBAFBE-5182-42C2-916E-E879A44CEE2DQ37308207-41E5131C-C4A0-424D-A1C2-B66856519EF5Q38358124-1502A6E6-A2BC-4DE0-A57C-9AB4FA455436Q38454458-FAF65751-9BEC-4F79-B442-CC2438B2365DQ38551944-87DBD024-49EB-4A21-9356-FA0C55CF094EQ38582930-26479FA4-2386-482F-ACC0-441D9268525FQ38686601-EEEC9F7C-E34E-4CBD-8A41-BAE6D08A9DF7Q38700209-92E0C669-FB44-42CE-832D-60A1DF87273AQ38840423-9A5C317F-C413-47FE-BD13-3A9238B5A132Q38995729-E87D588D-B431-4384-8413-45919BDF0F17Q45869295-EA8945FA-C69D-4AF1-AFCA-4A749F2E76E7Q47137165-3970CD41-7682-4F8B-BF4A-B2C934476371Q49987235-81C3CC4D-6974-4B90-8ED9-0F48558BA5E8Q50850473-FC177E3B-7D8F-4897-AC73-FD5C1219B082Q51141565-754C0865-C722-4770-B5A9-53E9E83443A9Q52379412-B0828998-A837-4836-80C6-4D6E252D91C7
P2860
The development of immunoconjugates for targeted cancer therapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The development of immunoconjugates for targeted cancer therapy
@ast
The development of immunoconjugates for targeted cancer therapy
@en
The development of immunoconjugates for targeted cancer therapy
@nl
type
label
The development of immunoconjugates for targeted cancer therapy
@ast
The development of immunoconjugates for targeted cancer therapy
@en
The development of immunoconjugates for targeted cancer therapy
@nl
prefLabel
The development of immunoconjugates for targeted cancer therapy
@ast
The development of immunoconjugates for targeted cancer therapy
@en
The development of immunoconjugates for targeted cancer therapy
@nl
P2093
P2860
P3181
P1476
The development of immunoconjugates for targeted cancer therapy
@en
P2093
Brandon G. Smaglo
Dalal Aldeghaither
Louis M. Weiner
P2860
P304
P3181
P356
10.1038/NRCLINONC.2014.159
P407
P577
2014-11-01T00:00:00Z